secwatch / observer
8-K filed September 27, 2024, 7:59 PM ET ticker PROV CIK 0001010470
other material confidence high sentiment positive materiality 0.40

Provident Financial extends stock repurchase plan by one year; 99,968 shares remain available

PROVIDENT FINANCIAL HOLDINGS INC

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000939057-24-000274
form_type
8-K
ticker
PROV
cik
0001010470
company_name
PROVIDENT FINANCIAL HOLDINGS INC
filed_at
2024-09-27T23:59:59+00:00
discovered_at
2026-05-14T18:03:11.868208+00:00
generated_at
2026-05-31T01:03:14.301142+00:00
sec_items
["8.01", "9.01"]
event_type
other_material
sentiment
positive
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000939057-24-000274
json_url
https://secwatch.observer/filing/0000939057-24-000274.json
markdown_url
https://secwatch.observer/filing/0000939057-24-000274.md
text_url
https://secwatch.observer/filing/0000939057-24-000274.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1010470/000093905724000274/0000939057-24-000274-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1010470/000093905724000274/prov8k92624.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

MXL

MaxLinear dismisses Grant Thornton, appoints KPMG as auditor for FY2026

MAXLINEAR, INC June 1, 2026, 4:35 PM ET other_material Items 4.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

LXU

LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026

LSB INDUSTRIES, INC. June 1, 2026, 4:35 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

SMC

Summit Midstream Corporation announces inaugural $35 million stock repurchase program

Summit Midstream Corp June 1, 2026, 4:31 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0000939057-24-000274

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.